Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 80

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 80
---
 the date of the meeting is first made. The nomination or proposal must be delivered to the Company’s executive offices at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, Attention: Corporate Secretary no earlier than March 13, 2026, and no later than April 12, 2026.

In addition, if a stockholder intends to utilize Rule 14a-19 under the Exchange act in connection with a nomination must give the requisite notice to the Company as indicated in the previous above sentence not later than the 60 thcalendar day in advance of the anniversary of the 2025 Annual Meeting, or May 12, 2026. Any stockholder considering submitting a nominee or proposal for action at our 2026 Annual Meeting of Stockholders is directed to the Company’s Bylaws, which contain additional requirements as to submission of nominations for directors or proposals for stockholder action. Copies of the Bylaws may be obtained upon request to the Company’s Corporate Secretary. Stockholder proposals or nominations must include the specified information concerning the stockholder and the proposal or nominee as described in our Bylaws.

<div align='center'>OTHER MATTERS</div>

The Board of Directors knows of no other business which will be presented to the Annual Meeting. If any other business is properly brought before the annual meeting, proxies will be voted in accordance with the judgment of the persons named therein.

<div align='center'>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

Our website is located at www.imunon.com. You can view additional information on our website, such as:

| ● | Charters                                                    
 of our Board Committees;                                    |
| ● | Code                                                        
 of Conduct; and                                             |
| ● | Other                                                       
 governance materials and reports that we file with the SEC. |

Copies of those documents may also be obtained free of charge by written or telephonic request directed to the Corporate Secretary, IMUNON, INC., 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648.

| June    
 9, 2025 | By                              
 Order of the Board of Directors |
|:--------|:--------------------------------|
|         | /s/                             
 Susan Eylward                   |
|         | Susan                           
 Eylward                         |
|         | General                         
 Counsel and Corporate Secretary |

| 60 |

<div align='center'>Exhibit A

CERTIFICATE OF AMENDMENT TO

RESTATED CERTIFICATE OF INCORPORATION OF

IMUNON